IXIARO + IXIARO
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 34/100
34
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Japanese Encephalitis
Conditions
Japanese Encephalitis
Trial Timeline
Dec 1, 2010 → Oct 1, 2013
NCT ID
NCT01296360About IXIARO + IXIARO
IXIARO + IXIARO is a phase 3 stage product being developed by Valneva SE for Japanese Encephalitis. The current trial status is completed. This product is registered under clinical trial identifier NCT01296360. Target conditions include Japanese Encephalitis.
What happened to similar drugs?
3 of 20 similar drugs in Japanese Encephalitis were approved
Approved (3) Terminated (0) Active (17)
Hype Score Breakdown
Clinical
17
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01296360 | Phase 3 | Completed |
Competing Products
20 competing products in Japanese Encephalitis